ATE515576T1 - Protein c polymorphismen - Google Patents
Protein c polymorphismenInfo
- Publication number
- ATE515576T1 ATE515576T1 AT03727058T AT03727058T ATE515576T1 AT E515576 T1 ATE515576 T1 AT E515576T1 AT 03727058 T AT03727058 T AT 03727058T AT 03727058 T AT03727058 T AT 03727058T AT E515576 T1 ATE515576 T1 AT E515576T1
- Authority
- AT
- Austria
- Prior art keywords
- patient
- protein
- inflammatory condition
- polymorphisms
- polymorphism
- Prior art date
Links
- 102000054765 polymorphisms of proteins Human genes 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 230000004968 inflammatory condition Effects 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 101800004937 Protein C Proteins 0.000 abstract 2
- 102100036546 Salivary acidic proline-rich phosphoprotein 1/2 Human genes 0.000 abstract 2
- 101800001700 Saposin-D Proteins 0.000 abstract 2
- 238000004393 prognosis Methods 0.000 abstract 2
- 229960000856 protein c Drugs 0.000 abstract 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38312802P | 2002-05-28 | 2002-05-28 | |
| PCT/CA2003/000751 WO2003100090A2 (en) | 2002-05-28 | 2003-05-28 | Protein c polymorphisms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE515576T1 true ATE515576T1 (de) | 2011-07-15 |
Family
ID=29584509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03727058T ATE515576T1 (de) | 2002-05-28 | 2003-05-28 | Protein c polymorphismen |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7820376B2 (de) |
| EP (1) | EP1507872B1 (de) |
| JP (2) | JP2005527218A (de) |
| AT (1) | ATE515576T1 (de) |
| AU (1) | AU2003233292A1 (de) |
| CA (1) | CA2487106A1 (de) |
| WO (1) | WO2003100090A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2558510A1 (en) * | 2004-03-04 | 2005-09-15 | The University Of British Columbia | Thrombomodulin (thbd) haplotypes predict outcome of patients |
| AU2005219473A1 (en) * | 2004-03-04 | 2005-09-15 | The University Of British Columbia | Toll-like receptor 2 (TLR-2) haplotypes predict outcome of patients |
| CA2479968A1 (en) | 2004-09-01 | 2006-03-01 | Keith R. Walley | Protein c and endothelial protein c receptor polymorphisms as indicators of patient outcome |
| WO2007079592A1 (en) * | 2006-01-12 | 2007-07-19 | The University Of British Columbia | Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration |
| MX2009008788A (es) * | 2007-02-16 | 2009-08-24 | Univ British Columbia | Poliformismos de serpine1 son predictivos de respuesta a administracion de proteina c activada y riesgo de muerte. |
| US20110092446A1 (en) * | 2007-07-20 | 2011-04-21 | Cedric Francois | Compositions and methods for treatment of trauma |
-
2003
- 2003-05-28 WO PCT/CA2003/000751 patent/WO2003100090A2/en active Application Filing
- 2003-05-28 EP EP03727058A patent/EP1507872B1/de not_active Expired - Lifetime
- 2003-05-28 AT AT03727058T patent/ATE515576T1/de not_active IP Right Cessation
- 2003-05-28 JP JP2004507530A patent/JP2005527218A/ja not_active Withdrawn
- 2003-05-28 CA CA002487106A patent/CA2487106A1/en not_active Abandoned
- 2003-05-28 US US10/515,493 patent/US7820376B2/en active Active
- 2003-05-28 AU AU2003233292A patent/AU2003233292A1/en not_active Abandoned
-
2010
- 2010-03-24 JP JP2010068029A patent/JP2010142252A/ja not_active Withdrawn
- 2010-09-30 US US12/895,295 patent/US20110020825A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003100090A2 (en) | 2003-12-04 |
| WO2003100090A3 (en) | 2004-04-08 |
| AU2003233292A8 (en) | 2003-12-12 |
| US20070128594A1 (en) | 2007-06-07 |
| AU2003233292A1 (en) | 2003-12-12 |
| JP2010142252A (ja) | 2010-07-01 |
| EP1507872B1 (de) | 2011-07-06 |
| US7820376B2 (en) | 2010-10-26 |
| EP1507872A2 (de) | 2005-02-23 |
| US20110020825A1 (en) | 2011-01-27 |
| JP2005527218A (ja) | 2005-09-15 |
| CA2487106A1 (en) | 2003-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1071710T4 (da) | Genomisk sekvens for 5-lipoxygenase-aktiveringsproteinet (FLAP), polymorfe markører deri og fremgangsmåder til påvisning af astma | |
| CA2735578C (en) | Method of identifying risk factors for alzheimer's disease comprising tomm40 gene variants | |
| ATE440151T1 (de) | Verfahren zur beurteilung eines krankheitzustandes mittels nachweis von partikel- und nicht partikelgebundenen nukleinsäuren in blutplasma und -serum | |
| DK1730315T3 (da) | Polymorphismer i NOD2/Card15 gen | |
| MY150648A (en) | Hla alleles associated with adverse drug reactions and methods for detecting such | |
| WO2007086980A3 (en) | Methods of determining the risk of developing coronary artery disease | |
| ATE482398T1 (de) | Verfahren zur stratifizierung von herzinsuffizienz | |
| TW200801200A (en) | Methods for determining probability of an adverse or favorable reaction to a niacin receptor agonist | |
| WO2006002930A3 (en) | FcϜRIIa POLYMORPHISM AND ITS USE IN DIAGNOSIS | |
| ATE515576T1 (de) | Protein c polymorphismen | |
| WO2004058051A3 (en) | Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions | |
| DK1529116T3 (da) | Fremgangsmåde til forudsigelse af respons på behandling med rivastigmin baseret på ApoE-genotypen hos demenspatienter | |
| WO2006053955A3 (en) | Method and kit for detecting a risk of essential arterial hypertension | |
| CY1111970T1 (el) | Μεθοδοι για την ανιχνευση της νοσου αλτσχαϊμερ | |
| WO2009033282A8 (en) | Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects | |
| WO2008048902A3 (en) | Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease | |
| ATE466104T1 (de) | Als indikatoren zur patientenprognose geeignete haplotypen von plasminogenaktivator-inhibitor-1 (pai-1) | |
| WO2002004683A3 (en) | Method of detecting an increased susceptibility to breast cancer | |
| WO2020230133A8 (en) | Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases | |
| DK1576187T3 (da) | Fremgangsmåde til bestemmelse af mængden af cirkulerende DNA i plasma samt påvisning af cancer | |
| DE602007010939D1 (de) | Abcbi-genotypisierung zur vorhersage der mikrotubuli-stabilisatorwirkstoffinduzierten toxizität | |
| DE60332158D1 (de) | Verfahren zur herzerkrankungsbewertung in einer einzelperson | |
| WO2003060158A3 (en) | Apoe genotype as a prognostic marker for hepatitis | |
| WO2006019984A3 (en) | Compositions, methods and kits for the diagnosis and treatment of sudden infant death syndrome | |
| ATE395437T1 (de) | Mit vorzeitiger canities in verbindung gebrachte polymorphismen von chromosom 9 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |